X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (36640) 36640
Newsletter (1441) 1441
Newspaper Article (1061) 1061
Magazine Article (99) 99
Book Chapter (46) 46
Book / eBook (30) 30
Publication (29) 29
Dissertation (22) 22
Government Document (13) 13
Web Resource (7) 7
Conference Proceeding (5) 5
Book Review (3) 3
Reference (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33145) 33145
male (29174) 29174
prostate cancer (21723) 21723
aged (15882) 15882
middle aged (15572) 15572
oncology (14439) 14439
cancer (14068) 14068
prostatic neoplasms - pathology (9483) 9483
prostatic neoplasms - mortality (8584) 8584
urology & nephrology (8136) 8136
research (7677) 7677
mortality (7450) 7450
female (7015) 7015
prognosis (6625) 6625
adult (6368) 6368
risk factors (6338) 6338
prostate (6317) 6317
aged, 80 and over (6047) 6047
care and treatment (5671) 5671
prostate-cancer (5651) 5651
prostate-specific antigen - blood (5243) 5243
metastasis (4885) 4885
prostatic neoplasms - diagnosis (4881) 4881
health aspects (4800) 4800
men (4613) 4613
prostatic neoplasms - surgery (4456) 4456
risk (4433) 4433
radical prostatectomy (4392) 4392
diagnosis (4250) 4250
analysis (4174) 4174
survival (4042) 4042
prostatic neoplasms - therapy (4027) 4027
neoplasm staging (4022) 4022
treatment outcome (4013) 4013
oncology, experimental (3781) 3781
prostatic neoplasms - drug therapy (3653) 3653
urology (3626) 3626
animals (3543) 3543
retrospective studies (3486) 3486
tumors (3456) 3456
carcinoma (3392) 3392
prostatectomy (3376) 3376
prostatic neoplasms - blood (3359) 3359
survival rate (3344) 3344
breast-cancer (3195) 3195
prostatic neoplasms - epidemiology (3141) 3141
radiotherapy (3057) 3057
follow-up studies (3051) 3051
cell line, tumor (3008) 3008
expression (2962) 2962
prostatic neoplasms - genetics (2926) 2926
surgery (2875) 2875
prostate-specific antigen (2624) 2624
prostatic neoplasms - radiotherapy (2583) 2583
survival analysis (2580) 2580
development and progression (2542) 2542
time factors (2437) 2437
prostatic neoplasms - metabolism (2435) 2435
epidemiology (2433) 2433
breast cancer (2376) 2376
prostatic neoplasms (2358) 2358
biopsy (2352) 2352
disease progression (2297) 2297
incidence (2276) 2276
cancer therapies (2274) 2274
disease-free survival (2272) 2272
apoptosis (2250) 2250
medicine & public health (2250) 2250
patients (2212) 2212
gene expression (2199) 2199
chemotherapy (2160) 2160
studies (2154) 2154
genetic aspects (2153) 2153
medicine (2087) 2087
cohort studies (2045) 2045
risk assessment (2039) 2039
research article (1999) 1999
proteins (1954) 1954
mice (1935) 1935
public, environmental & occupational health (1907) 1907
therapy (1903) 1903
neoplasm grading (1896) 1896
patient outcomes (1896) 1896
progression (1883) 1883
abridged index medicus (1875) 1875
antigen (1874) 1874
proportional hazards models (1866) 1866
prostate - pathology (1807) 1807
prospective studies (1789) 1789
medical research (1769) 1769
medicine, general & internal (1756) 1756
medical prognosis (1706) 1706
androgen antagonists - therapeutic use (1689) 1689
biomarkers (1689) 1689
immunohistochemistry (1687) 1687
neoplasm metastasis (1646) 1646
antigens (1639) 1639
metastases (1601) 1601
gene expression regulation, neoplastic (1591) 1591
prostatectomy - methods (1576) 1576
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (7) 7
Gerstein Science - Stacks (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (38344) 38344
German (419) 419
French (296) 296
Japanese (255) 255
Spanish (205) 205
Portuguese (97) 97
Russian (65) 65
Chinese (39) 39
Italian (35) 35
Norwegian (29) 29
Swedish (27) 27
Danish (22) 22
Dutch (22) 22
Turkish (17) 17
Polish (13) 13
Hebrew (12) 12
Czech (11) 11
Hungarian (10) 10
Finnish (5) 5
Arabic (3) 3
Croatian (3) 3
Lithuanian (3) 3
Korean (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Greek (1) 1
Indonesian (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of oncology, ISSN 0923-7534, 2003, Volume 14, Issue 5, pp. v61 - v118
EUROCARE-3 analysed the survival of 1815584 adult cancer patients diagnosed from 1990 to 1994 in 22 European countries. The results are reported in tables, one... 
international comparison | Europe | population-based cancer registries | age-standardised relative survival | cancer survival | Cancer survival | Population-based cancer registries | Age-standardised relative survival | International comparison | PROSTATE | ADULT PATIENTS | PROGNOSIS | STAGE | TESTICULAR CANCER | TRENDS | TUMORS | BREAST-CANCER | LUNG-CANCER | ONCOLOGY | Urologic Neoplasms - epidemiology | Testicular Neoplasms - mortality | Digestive System Neoplasms - mortality | Lung Neoplasms - mortality | Hematologic Neoplasms - mortality | Humans | Thyroid Neoplasms - epidemiology | Male | Neoplasms - diagnosis | Testicular Neoplasms - epidemiology | Hematologic Neoplasms - epidemiology | Genital Neoplasms, Female - epidemiology | Registries - statistics & numerical data | Skin Neoplasms - mortality | Head and Neck Neoplasms - epidemiology | Female | Brain Neoplasms - mortality | Breast Neoplasms - epidemiology | Digestive System Neoplasms - epidemiology | Thyroid Neoplasms - mortality | Urologic Neoplasms - mortality | Europe - epidemiology | Neoplasms - mortality | Survival Rate | Skin Neoplasms - epidemiology | Prostatic Neoplasms - mortality | Prostatic Neoplasms - epidemiology | Genital Neoplasms, Female - mortality | Lung Neoplasms - epidemiology | Sex Factors | Survival Analysis | Breast Neoplasms - mortality | Head and Neck Neoplasms - mortality | Neoplasms - epidemiology | Brain Neoplasms - epidemiology
Journal Article
Cancer causes & control, ISSN 1573-7225, 2008, Volume 20, Issue 4, pp. 417 - 435
.... representative National Longitudinal Mortality Study (NLMS) data provide self-reported, detailed demographic and socioeconomic data from the Social and Economic Supplement to the Census Bureau's Current Population Survey (CPS... 
Socioeconomic status | Prophets | Mortality | Censuses | Cancer incidence | Breast cancer | Socioeconomics | Educational attainment | Lung neoplasms | Cancer | NLMS | SES | Poverty | Hematology | Rural/urban | Income | Oncology | Record linkage | Public Health/Gesundheitswesen | Epidemiology | Unemployment | Biomedicine general | Biomedicine | Education | Race/ethnicity | Cancer Research | SEER | Stage | Health disparities | RACIAL-DIFFERENCES | BREAST-CANCER | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PROSTATE-CANCER | UNITED-STATES | CERVICAL-CANCER | RESULTS PROGRAM | US WOMEN | SOCIAL-CLASS | DEATH INDEX | ONCOLOGY | COLORECTAL-CANCER | Melanoma - epidemiology | Lung Neoplasms - ethnology | United States - epidemiology | Uterine Cervical Neoplasms - ethnology | Lung Neoplasms - mortality | Humans | Survivors - statistics & numerical data | Uterine Cervical Neoplasms - epidemiology | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Incidence | Neoplasms - ethnology | Female | Registries | Medical Record Linkage | Breast Neoplasms - ethnology | Uterine Cervical Neoplasms - mortality | Breast Neoplasms - epidemiology | Ethnic Groups - statistics & numerical data | Prostatic Neoplasms - pathology | SEER Program | Melanoma - ethnology | Neoplasms - mortality | Prostatic Neoplasms - ethnology | Melanoma - pathology | Prostatic Neoplasms - mortality | Social Class | Prostatic Neoplasms - epidemiology | Lung Neoplasms - epidemiology | Breast Neoplasms - pathology | Healthcare Disparities | Breast Neoplasms - mortality | Neoplasm Staging | Neoplasms - pathology | Longitudinal Studies | Neoplasms - epidemiology | Cohort Studies | Melanoma - mortality | Social classes | Usage | Demographic aspects | Social aspects | Health aspects | Epidemiologic methods | Rural | ethnicity | Original Paper | urban | Race
Journal Article
Journal Article
World Journal of Urology, ISSN 0724-4983, 4/2014, Volume 32, Issue 2, pp. 475 - 479
Our aim was to assess the effect of surgical wait time on the survival of patients with urological neoplasms, including prostate, bladder, penile, and testicular cancers and upper tract tumours (UTUC... 
Nephrology | Medicine & Public Health | Urology/Andrology | Renal cell carcinoma | Surgery | Oncology | Urothelial carcinoma | Waiting time | Survival | Prostate cancer | BLADDER-CANCER | SMALL RENAL MASSES | MANAGEMENT | RADICAL PROSTATECTOMY | SURVEILLANCE | UROLOGY & NEPHROLOGY | CYSTECTOMY | QUALITY-OF-LIFE | DELAY | Carcinoma, Transitional Cell - mortality | Penile Neoplasms - diagnosis | Prostatectomy - methods | Testicular Neoplasms - mortality | Urologic Neoplasms - diagnosis | Urinary Bladder Neoplasms - diagnosis | Humans | Carcinoma, Renal Cell - surgery | Male | Prostatic Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - diagnosis | Nephrectomy - methods | Kidney Neoplasms - diagnosis | Testicular Neoplasms - surgery | Kidney Neoplasms - surgery | Time Factors | Neoplasms, Germ Cell and Embryonal - mortality | Penile Neoplasms - mortality | Testicular Neoplasms - diagnosis | Urinary Bladder Neoplasms - mortality | Prostatic Neoplasms - surgery | Time-to-Treatment | Urologic Neoplasms - mortality | Carcinoma, Transitional Cell - diagnosis | Kidney Neoplasms - mortality | Urinary Bladder Neoplasms - surgery | Prostatic Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Penile Neoplasms - surgery | Carcinoma, Renal Cell - diagnosis | Ureteral Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - surgery | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Cystectomy - methods | Orchiectomy - methods | Urologic Neoplasms - surgery | Diagnosis | Health aspects | Tumors
Journal Article
European urology, ISSN 0302-2838, 2014, Volume 65, Issue 2, pp. 270 - 273
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 676 - 681
...) of grades II to IV was 47%, and that of chronic GVHD was 32%. Treatment-related mortality was 21%. At 5... 
Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Allogeneic hematopoietic stem cell transplantation | Colon carcinoma | Renal carcinoma | Cholangiocarcinoma | DONOR | BONE-MARROW | GRAFT | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | BREAST-CANCER | PRIMARY LIVER-CANCER | LEUKEMIA | HEMATOLOGY | COLON-CARCINOMA | MARROW TRANSPLANTATION | BLOOD | Adenocarcinoma - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Kidney Neoplasms - immunology | Male | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Bile Duct Neoplasms - immunology | Neoplasm Metastasis | Graft vs Host Disease - mortality | Colonic Neoplasms - immunology | Adult | Female | Pancreatic Neoplasms - mortality | Transplantation Conditioning - methods | Graft vs Host Disease - diagnosis | Kidney Neoplasms - therapy | Colonic Neoplasms - therapy | Prostatic Neoplasms - pathology | Colonic Neoplasms - mortality | Adenocarcinoma - immunology | Pancreatic Neoplasms - pathology | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Kidney Neoplasms - mortality | Myeloablative Agonists | Prostatic Neoplasms - mortality | Graft vs Host Disease - pathology | Bile Duct Neoplasms - therapy | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Bile Duct Neoplasms - mortality | Colonic Neoplasms - pathology | Pancreatic Neoplasms - immunology | Survival Analysis | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Aged | Bile Duct Neoplasms - pathology | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Liver cancer | Colon cancer | Pancreatic cancer | Liver | Mortality | Stem cells | Transplantation | Metastasis | Health aspects | Prostate cancer | Risk factors | Hematopoietic stem cells | College teachers
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 2016, Volume 66, Issue 4, pp. 271 - 289
The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For... 
prevalence | survivorship | treatment patterns | statistics | LYMPH-NODE DISSECTION | ADJUVANT CHEMOTHERAPY | SELECTIVE BLADDER PRESERVATION | LONG-TERM SURVIVORS | BREAST-CONSERVING THERAPY | METASTATIC PROSTATE-CANCER | ANDROGEN-DEPRIVATION THERAPY | ONCOLOGY | COLORECTAL-CANCER | CARDIOVASCULAR-DISEASE | QUALITY-OF-LIFE | Uterine Neoplasms - therapy | United States - epidemiology | Prevalence | Humans | Middle Aged | Survivors - statistics & numerical data | Child, Preschool | National Cancer Institute (U.S.) | Infant | Male | Neoplasms - diagnosis | Incidence | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | American Cancer Society | Neoplasms - therapy | Skin Neoplasms - mortality | Aged, 80 and over | Uterine Neoplasms - mortality | Adult | Female | Registries | Child | Infant, Newborn | Colonic Neoplasms - therapy | Colonic Neoplasms - mortality | Skin Neoplasms - therapy | Risk Factors | Neoplasms - mortality | Survival Rate | Evidence-Based Medicine | Prostatic Neoplasms - mortality | Adolescent | Breast Neoplasms - mortality | Aged | Melanoma - therapy | Neoplasms - epidemiology | Melanoma - mortality | Care and treatment | Management | Primary health care | Analysis | Public health | Cancer | Survivor | Oncology | Family medical history | Disease management | Medical diagnosis | Medical statistics | Primary care
Journal Article